CVS Health Corporation (CVS)
| Market Cap | 87.36B |
| Revenue (ttm) | 370.66B |
| Net Income (ttm) | 4.61B |
| Shares Out | 1.26B |
| EPS (ttm) | 3.66 |
| PE Ratio | 18.91 |
| Forward PE | 11.73 |
| Dividend | $2.66 (3.84%) |
| Ex-Dividend Date | Apr 22, 2025 |
| Volume | 5,478,255 |
| Open | 70.00 |
| Previous Close | 69.51 |
| Day's Range | 68.83 - 70.02 |
| 52-Week Range | 43.56 - 71.66 |
| Beta | 0.57 |
| Analysts | Buy |
| Price Target | 71.38 (+3.15%) |
| Earnings Date | May 1, 2025 |
About CVS
CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, Medicare Advantage and Medicare Supplement plans, PDPs and Medicaid health care management services. It serves employer groups, individuals, coll... [Read more]
Financial Performance
In 2024, CVS Health's revenue was $370.66 billion, an increase of 3.93% compared to the previous year's $356.62 billion. Earnings were $4.61 billion, a decrease of -44.70%.
Financial StatementsAnalyst Forecast
According to 16 analysts, the average rating for CVS stock is "Buy." The 12-month stock price forecast is $71.38, which is an increase of 3.15% from the latest price.
News
CVS Health: Maybe The Right Investment At The Right Time
CVS Health Corporation surged 10% intraday and ended yesterday 6% higher, driven by a new CFO announcement and increased Medicare Advantage payments. Despite a challenging fiscal 2024, CVS is underval...
These 20 stocks have risen during Trump's trade tirade. Analysts see up to 30% additional upside.
The stock market doesn't react well to uncertainty. And the daily headlines about new tariffs being placed on U.S. imports and possible negotiations with trading partners to do away with tariffs have ...
Mizuho's Jared Holz: Here's why healthcare stocks are under pressure
Jared Holz, Mizuho Securities America healthcare sector strategist, joins CNBC's 'Power Lunch' to discuss whether the healthcare sector is actually a safe haven during the market turmoil, why healthca...
Measuring WBA Merger, HUM "Bonds Play," CVS & UNH Options Trades
Spencer Hakimian believes the healthcare sector will withstand the tariff storm well compared to other industries. On specific stocks, he doesn't expect much movement from Walgreens (WBA) after its to...
US Health Insurance Stocks Rally After $25 Billion Federal Boost To Medicare Payments
Health insurance stocks soared Tuesday morning on the first full day of trading after the U.S. government announced a more than 5% average increase in government reimbursement rates for 2026 Medicare ...
Humana and Other Health Insurance Stocks Surge on Higher-Than-Expected Medicare Payments
Shares of health insurance operators surged Tuesday after the government said it would pay a higher rate to Medicare insurers than previously estimated.
Health Insurer Stocks Soar on Medicare Rate Boost
Medicare Advantage plans will get a 5.06% rate increase, well above the 2.23% bump that the Biden administration proposed.
CVS Health Appoints Former UPS And Pepsi Exec As Finance Chief, Stock Soars
CVS Health Inc CVS on Tuesday named Brian Newman as executive vice president and chief financial officer designate, effective April 21.
CVS Health Taps Brian Newman as CFO
The health solutions company named Brian Newman as chief financial officer and said that it expects to meet or exceed its latest guidance for the year.
CVS names UPS executive Brian Newman as CFO
CVS Health on Tuesday named United Parcel Service executive Brian Newman as its new chief financial officer, in the first top management change for the health insurer under the leadership of CEO David...
CVS Health Announces Chief Financial Officer Transition Plan; Appoints Chief Medical Officer
WOONSOCKET, R.I. , April 8, 2025 /PRNewswire/ -- CVS Health® (NYSE: CVS) today announced two leadership updates.
Health insurance stocks rise on 'best case scenario' Medicare payment rates
Shares of U.S. health insurers jumped on Tuesday after a bigger-than-expected increase in the government's reimbursement rates for Medicare Advantage plans in 2026, bringing some relief to a sector bu...
CVS Health's financial chief to step down, Bloomberg News reports
CVS Health Corp Chief Financial Officer Thomas Cowhey intends to step down from his position, Bloomberg News reported on Monday, citing people familiar with the matter.
CVS Health's Trough Years Are Here - Double Digits Return Profile Ahead
CVS has been worst hit by the rising healthcare utilization/ medical costs, as observed in the relatively higher medical benefit ratio in FQ4'24/ FY2024 compared to its peers. Even so, we believe that...
CVS Health: Undervalued, But The Road To Success Is Paved With Uncertainty
I rate CVS Health as a BUY due to its undervaluation and potential for financial growth despite current sector uncertainties. CVS's revenue is growing, but profitability is declining due to retail com...
3 Nearly Trump-Proof Stocks Defying Trump's Tariff Shock
The S&P 500's three top performers in 2025 boast characteristics that could help them weather a further sell off.
CVS Health to hold first quarter 2025 earnings conference call
WOONSOCKET, R.I. , April 3, 2025 /PRNewswire/ -- CVS Health® (NYSE: CVS) will hold a conference call with analysts and investors on Thursday, May 1 st, 2025, at 8:00 a.m.
Biotech Stocks Q1 2025 Recap: Winners And Underperformers
Investing in biotech can be highly rewarding but is fraught with risks; understanding past catalysts can help investors make informed decisions and minimize downside risk. CervoMed Inc. surged over 30...
CVS Health and Deckers Are the S&P 500's Best and Worst for the Quarter. Here's Why.
CVS Health gained 50% over the three-month period while Deckers fell nearly as much.
Stocks: Best and worst performers of Q1
On the final day of the first quarter of 2025, Madison Mills and Julie Hyman take a look at the best and worst-performing stocks and sectors of the year so far. Among the worst performers are Deckers ...
CVS Health: I Don't Understand The Fuss, But The Worst Is Behind
CVS Health experienced a significant turnaround in 2025, with shares up nearly 50% after a 44% decline in 2024. The recent rally is not driven by great results or strong guidance under new CEO leaders...
Trade Tracker: Joe Terranova buys Interactive Brokers and McKesson, sells CVS
Joe Terranova, Senior Managing Director for Virtus Investment Partners, joins CNBC's "Halftime Report" to detail his latest portfolio moves.
Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high...
CVS Health declares quarterly dividend
WOONSOCKET, R.I. , March 20, 2025 /PRNewswire/ -- CVS Health® (NYSE: CVS) has announced that its board of directors has approved a quarterly dividend of sixty-six and one-half cents ($0.665 cents) per...
My Dividend Stock Portfolio: New February Dividend Record - 100 Holdings With 11 Buys
February investments fell below $1,000, mainly in BDCs like Owl Rock Capital and Ares Capital, boosting annual dividend income by $77. Dividend income hit a new February record of $505, up 5% Y/Y driv...